Guest guest Posted February 19, 2011 Report Share Posted February 19, 2011 Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malig Who Relapse/Progress After Rituximab http://bit.ly/g6TnCs The suggestion here is that lymphoma/CLL with CD5 positivity (perhaps indicating signficant t-cell infiltration) may respond well to this combination therapy. It's a small study, so this inquiry should be considered exploratory - to see if further study of L with R is warranted in cd5+ lymphoma. Patients Against Lymphoma Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.